Jr. Michael Conick Hanley - 20 May 2024 Form 3 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Chief Operating Officer
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
20 May 2024
Net transactions value
$0
Form type
3
Filing time
22 May 2024, 17:17:40 UTC
Previous filing
24 Feb 2023
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANRO Stock Option (right to buy) 20 May 2024 Common Stock 8,000 $14.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on each of March 22, 2024, April 22, 2024, May 22, 2024, and June 20, 2024, subject to the Reporting Person's continuous service through each vesting date. The option was granted pursuant to a consulting agreement between the Issuer and the Reporting Person dated July 20, 2023, as amended on February 22, 2024.